News

For additional media information, contact:
Arthur J. Shannon, Vice President, Investor Relations and Communications
ajshannon@perrigo.com
269-686-1709(direct)
269-673-9128 (fax)

Archive: 2008 |2007 |2006  | 2005  |  2004  |  2003 |  2002

2009

Perrigo Reports Record Third Quarter
May 7, 2009
See Attachment

Perrigo Announces Quarterly Dividend
May 6, 2009
See Attachment

Perrigo Will Release Third Quarter Fiscal Year 2009 Results on May 7, 2009
April 22, 2009
See Attachment

Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
March 24, 2009
See Attachment

Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R)
March 17, 2009
See Attachment

Perrigo Begins Shipments of Ibuprofen PM
February 20, 2009
See Attachment

Perrigo Reports Record Second Quarter Sales
February 3, 2009
See Attachment

Perrigo Announces Quarterly Dividend
January 28, 2009
See Attachment

Perrigo Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
January 21, 2009
See Attachment